PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 130 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,556,000 | -73.1% | 144,624 | -68.2% | 0.20% | -50.2% |
| Q2 2019 | $5,774,000 | -73.9% | 454,300 | -20.4% | 0.40% | -61.0% |
| Q1 2019 | $22,141,000 | +129.5% | 570,800 | +20.4% | 1.02% | +54.1% |
| Q4 2018 | $9,647,000 | +147.3% | 474,100 | +457.1% | 0.66% | +198.2% |
| Q3 2018 | $3,901,000 | -22.5% | 85,100 | 0.0% | 0.22% | -24.4% |
| Q2 2018 | $5,033,000 | +158.5% | 85,100 | +332.0% | 0.30% | +183.7% |
| Q4 2017 | $1,947,000 | -46.6% | 19,700 | -83.4% | 0.10% | -65.3% |
| Q4 2016 | $3,644,000 | – | 118,700 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |